Product
Inosine
2 clinical trials
2 indications
Indication
Triple-negative Breast CancerIndication
Advanced Solid TumorClinical trial
a Pilot Study to Explore the Efficacy of Inosine Reversing Chemo Resistance in Triple Negative Breast CancerStatus: Not yet recruiting, Estimated PCD: 2024-12-31
Clinical trial
Gut Microbial Metabolites Inosine Combined With PD-1/PD-L1 Inhibitor for Patients With Malignant Advanced Solid TumorsStatus: Completed, Estimated PCD: 2022-10-31